Past eventHeld 13–15 October 2026
World Patient Safety Congress Americas 2026
A conference and exhibition covering AI and automation, patient centricity, quality assurance, signal management, outsourcing, and risk management in pharmacovigilance and patient safety.
Thomas M. Menino Convention & Exhibition Center, Boston
- Held
- 13–15 October 2026
- Venue
- Thomas M. Menino Convention & Exhibition Center, Boston
TL;DR
- World Patient Safety Congress Americas 2026 took place 13–15 October at Thomas M. Menino Convention & Exhibition Center in Boston.
- It was a conference and exhibition covering AI and automation, patient centricity, quality assurance, signal management, outsourcing, and risk management in pharmacovigilance and patient safety.
- The programme was scheduled to include pre-congress workshops on October 13 and main congress days on October 14–15.
Source: terrapinn.com/conference/world-patient-safety-congress-us
About
The event was billed as bringing C-suite, R&D, and data leaders together around the future of patient safety. Terrapinn organised the 2026 edition. Its billed coverage included benefit-risk management, patient-centric approaches, and next-generation AI safety solutions across regulated product categories.
Who was in the room
C-suite, R&D, and data leaders
Leaders in patient safety and pharmacovigilance.
Public posts about this edition
3 postsQuoted word for word from public posts; each links to the original.
“At the booth, AI-native NavaX and XDI kept the connections going with PV leaders at every stage of adoption.”
ArisGlobal
Read the post“We are live at the World Patient Safety Congress Americas in Boston!”
Navitas Life Sciences
Read the post“The conversations are underway in Boston, and 4C Pharma Solutions is excited to connect with industry leaders shaping the future of patient safety and pharmacovigilance.”
4C Pharma Solutions
Read the post
Featured speakers
30 listedFelix Arellano
SVP, Global Head of Safety and Risk Management · Roche
Mariette Boerstoel
SVP, Worldwide Patient Safety Officer · Bristol Myers Squibb
Tanmay Desai
Head, Global PV Operations · Kyowa Kirin
Karthik Muthusamy
Executive Director, Head of Patient Safety · Novo Nordisk
Pav Rishiraj
Director, Head of Patient Safety & ABPI PV Expert Chair · Ipsen & ABPI
Aysha Amman
Senior Director, Patient Safety & Pharmacovigilance · Amneal Pharmaceuticals
Peter Hjelmstrom
Director and CEO · Uppsala Monitoring Centre
Juhaeri Juhaeri
VP & Global Head, Epidemiology and Benefit-Risk · Sanofi
Rohan Nanda
Executive Medical Director & Early Phase Drug Physician · Eli Lilly and Company
James Buchanan
Co-Lead · ASA Biopharmaceutical Safety Working Group
Juan Daccach
VP, Global Product Safety · Merz Aesthetics
William Blumentals
Head of Pharmacoepidemiology, Specialty Care · Sanofi
Janaina Brothers
Senior Manager, Medical Safety · Jazz Pharmaceuticals
Siva Kumar Buddha
Medical Director, Global Patient Safety · Amgen
Nirjhar Chatterjee
Senior MD Pharmacovigilance · Crinetics
Tasia-Leigh Deleon
Manager, Cosmetovigilance · Chanel
Joshua Gagne
VP and Global Head of Epidemiology · Janssen Global Services
Israel Gutierrez
Chief Medical Officer · TLR Therapeutics
Shefali Jobanputra
CPASS Compliance, Process and Training Lead · Takeda
Ankit Lodaya
Senior Director Pharmacovigilance · Beam Therapeutics
Reema Mehta
VP, Head of Risk Assessment and Management · Pfizer
Ella Nnadili-Okonkwo
Sr. Medical Director, Global Clinical Safety Lead · Moderna Therapeutics
Anuj Parikh
Associate Medical Director · Jazz Pharmaceuticals
E. Alton Sartor
Medical Director, Safety Digital and Devices · AstraZeneca
Dana Singer
Medical Director · Jazz Pharmaceuticals
Tarak Thakker
Director, Safety Systems and Reporting · BeOne Medicines
Dennis Van Liew
Board Member Emeritus · Personalized Medicine Coalition
Michael von Forstner
Chief Scientific Officer · MedGenie
Deb Wright
Director, PV Operations · Jazz Pharmaceuticals
Oleg Zvenigorodsky
Director, Medical Safety · Jazz Pharmaceuticals
Partners on record
9 listedWhat attendees say
“The WPSC Americas is one of the best meetings in the PV space gathering both scientific, industrial and regulatory thought leaders discussing why and how. It is occupying a sweet spot where other meetings are either more policy-oriented or more commercially oriented.”
Venue & travel
Venue
Thomas M. Menino Convention & Exhibition CenterQuestions people ask
6 answeredThe next edition, World Patient Safety Congress Americas 2027, is scheduled for November 16-18, 2027 in Boston, MA.
World Patient Safety Congress Americas 2026 took place from 13–15 October 2026.
It was held at Thomas M. Menino Convention & Exhibition Center in Boston, Massachusetts.
The organizer identified C-suite, R&D, and data leaders in patient safety and pharmacovigilance as the audience.
It was most useful for pharmacovigilance and patient safety leads at drug makers, since the speaker list was dominated by safety, epidemiology and medical safety heads from companies such as Roche, Bristol Myers Squibb, Sanofi, Pfizer and Amgen, alongside the Uppsala Monitoring Centre. The program covered AI and automation, signal management, quality assurance, outsourcing and risk management, which suited teams weighing vendor and process choices, and the sponsor roster included safety service and software providers such as IQVIA, Clarivate and PharSafer. Clinicians outside industry, or those who wanted policy-level regulatory debate, would have gotten less from it than pharmacovigilance professionals comparing notes with peers.
Attendees at pharmaceutical and pharmacovigilance conferences usually wear business casual to business formal, such as slacks or a blazer, with no tie needed for most. Comfortable shoes help at a large convention center like the Thomas M. Menino Convention & Exhibition Center, and a layer suits Boston in mid-October.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.
Also listed in